Glycyx Therapeutics
Clinical trials sponsored by Glycyx Therapeutics, explained in plain language.
-
New pill may ease constipation from painkillers
Symptom relief CompletedThis study tested a drug called TD-1211 in healthy people and those with constipation caused by opioid painkillers. The goal was to see if it is safe and helps with bowel movements. About 102 adults took part, and they had to stop using other laxatives during the study.
Phase: PHASE1, PHASE2 • Sponsor: Glycyx Therapeutics • Aim: Symptom relief
Last updated May 26, 2026 04:59 UTC
-
New pill aims to relieve constipation from pain meds
Symptom relief CompletedThis study tested a drug called TD-1211 in 69 adults who had constipation because of opioid painkillers. The goal was to see if it is safe and helps people have more bowel movements. Participants stopped using other laxatives during the study.
Phase: PHASE2 • Sponsor: Glycyx Therapeutics • Aim: Symptom relief
Last updated May 26, 2026 04:52 UTC
-
Scientists track mystery Drug's journey through healthy men
Knowledge-focused CompletedThis study looked at how the body processes TD-1211, a drug for opioid-induced constipation. Ten healthy men received the drug by mouth and by IV to track its absorption, breakdown, and removal. The goal was purely to understand the drug's behavior, not to treat any condition.
Phase: PHASE1 • Sponsor: Glycyx Therapeutics • Aim: Knowledge-focused
Last updated May 26, 2026 04:58 UTC
-
Healthy volunteers needed to test drug interaction
Knowledge-focused CompletedThis study looks at how a common antifungal drug (itraconazole) changes the way the body handles an experimental drug called TD-1211. Twenty healthy adults aged 18 to 50 will take a single dose of TD-1211 with and without itraconazole. Researchers will measure drug levels in the …
Phase: PHASE1 • Sponsor: Glycyx Therapeutics • Aim: Knowledge-focused
Last updated May 26, 2026 04:38 UTC